Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Gene Therapy
University of Colorado, Department of Surgery publishes research in cancer gene therapy
November 11th, 2008
Researchers detail in 'Focal adhesion kinase controls aggressive phenotype of androgen-independent prostate cancer,' new data in cancer gene therapy. According to recent research from the United States, "Overexpression of focal adhesion kinase (FAK) has been well correlated with tumor development and/or the maintenance of tumor phenotype. In addition, inappropriate activation of the extracellular regulated kinase (ERK) signaling pathway is common to many human cancers." "In the present study, we investigated the interplay between FAK and ERK in androgen-independent prostate cancer cells (PC3 and DU145 cells). We observed that suppression of FAK expression using small...
Source: Cancer Weekly (2008-11-11)
|
